MediLink Therapeutics, founded in 2020, is a clinical stage biotech company dedicated to developing conjugated drugs

Both Roche and Hitachi High-Tech share the vision to drive innovation in in-vitro diagnostics to solve healthcare challenges

This investment represents the single largest investment in synthetic medicine API manufacturing in US history.

SOMNUM is an algorithm that is integrable into any medical and healthcare market using real-time large-scale bio signal.

The company's multi-therapeutic pipeline is pursuing Parkinson's-related disorders of the brain and GI tract

Progentos is developing first-in-class compounds to induce endogenous oligodendrocyte progenitor cells to remyelinate axons in patients

In human studies the Hemopurifier has demonstrated the removal of life-threatening viruses and the removal of harmful exosomes

the company offers an app and teletherapy services designed to provide accessible, inclusive, and comprehensive mental health support

R3 Vascular will use the proceeds to support the ELITE FDA IDE trial of its bioresorbable scaffold, MAGNITUDE, for below-the-knee pad

oloSeal™ has the potential to help over 100,000 patients annually who undergo colorectal surgeries

Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors.

With its autonomous blood draw technology Vitestro is transforming the blood draw industry globally.

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent...

By focusing on the individual as a whole person and addressing their long-term needs, we create lasting change for our members.